Lansing Street Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$63.6K Hold
265
0.04% 129
2023
Q1
$49.8K Hold
265
0.03% 142
2022
Q4
$56.3K Hold
265
0.04% 143
2022
Q3
$42K Hold
265
0.03% 139
2022
Q2
$40K Hold
265
0.03% 134
2022
Q1
$44K Buy
+265
New +$43.7K 0.03% 139

Other funds holding MEDP

Lansing Street Advisors's MEDP Position: Q2 2023 in Review

Lansing Street Advisors held its Medpace (MEDP) position steady in Q2 2023 at 265 shares worth $63.6K. The position accounts for 0.04% of the portfolio, ranked #129.

Lansing Street Advisors first reported a position in MEDP in Q1 2022 and has held it in 6 quarters since. 464 funds tracked by Wall St. Rank hold MEDP as of Q2 2023.

  • Lansing Street Advisors held 265 shares of Medpace worth $63.6K as of Q2 2023.
  • Lansing Street Advisors left its Medpace share count unchanged in Q2 2023.
  • Medpace made up 0.04% of Lansing Street Advisors's portfolio in Q2 2023, its #129 holding.
  • Lansing Street Advisors first reported a position in Medpace in Q1 2022 and has held it in 6 quarters since.
  • 464 funds tracked by Wall St. Rank held Medpace as of Q2 2023.

Based on Lansing Street Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.